Header Logo

Connection

David Bennett to Alemtuzumab

Back to Details
This is a "connection" page, showing publications David Bennett has written about Alemtuzumab.
David Bennett
Connection Strength
0.016
Alemtuzumab
  1. Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005 Aug 20; 23(24):5728-38.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.